COMPLETED

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.

Official Title

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Quick Facts

Study Start:2021-04-24
Study Completion:2025-11-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04876846

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Women with singleton, healthy pregnancy at gestational age ≥ 36 weeks
  2. 2. Age \> 18 years
  3. 3. Willing to come in for testing outside of routine business hours (including Saturdays)
  1. 1. Age \<18
  2. 2. Multiple gestation (twins, triplets)
  3. 3. Presentation other than vertex or breech
  4. 4. \< 36 weeks of gestation

Contacts and Locations

Principal Investigator

Mark Rosen, MD
STUDY_DIRECTOR
Raydiant Oximetry

Study Locations (Sites)

Yaron Friedman, MD, Inc.
Walnut Creek, California, 94598
United States

Collaborators and Investigators

Sponsor: Raydiant Oximetry, Inc.

  • Mark Rosen, MD, STUDY_DIRECTOR, Raydiant Oximetry

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-24
Study Completion Date2025-11-11

Study Record Updates

Study Start Date2021-04-24
Study Completion Date2025-11-11

Terms related to this study

Additional Relevant MeSH Terms

  • Fetal Hypoxia